Olga Libova, CNM
Advanced Practice Midwife · Mountain View, CANPI 1316072572
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Sumitomo Pharma America, Inc. at 39.5% of the total. Reporting peaked in 2023 at $2,204 and has fallen 88.1% since, to $262 in 2025. Among advanced practice midwife clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 25 payments — averaging $181.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$2K
- Myovant Sciences Inc.$1K
- AbbVie$296
- Neurocrine Biosciences, Inc.$136
- Vertos Medical, Inc.$128
- Gilead$125
- plus $954 from 11 others
What the payments were for
- Speaking & faculty fees$1,74538%
- Travel & lodging$1,02223%
- Food & beverage$1,76639%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $1,790 |
| Myovant Sciences Inc. | 4 | $1,105 |
| AbbVie | 4 | $296 |
| Neurocrine Biosciences, Inc. | 1 | $136 |
| Vertos Medical, Inc. | 1 | $128 |
| Gilead | 1 | $125 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $125 |
| Amgen | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Johnson & Johnson | 1 | $109 |
| Biohaven Pharmaceuticals, Inc. | 1 | $109 |
| Biogen | 1 | $106 |
| Axsome Therapeutics, Inc. | 1 | $99 |
| Intercept Pharmaceuticals, Inc. | 1 | $88 |
| Hologic Sales And Service, LLC | 1 | $29 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| BD | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYFEMBREE$1,022
- VRAYLAR$250
- JYNARQUE$247
- INGREZZA$136
- mild Device Kit$128
- EVENITY$125
- SPRAVATO$109
- NURTEC ODT$109
- Zurzuvae$106
How this compares
$4,534 in reported general payments places this provider in the 95th percentile of 451 advanced practice midwife providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 15 | $1,010 |
Paid to pharmacies, not to this prescriber.
Other advanced practice midwife in Mountain View
- Kathryn MillarMountain View$826
- Candace MooneyTemecula$32K
- Jeri SanchezMoreno Valley$13K
- Faye BatesVisalia$8K
- Anne LeeFallbrook$5K
- Andrea Dorwart CraneIrvine$5K
- Journey TalkovicSanta Cruz$4K
- Jodie TorromeoLong Beach$3K
- Carla BushSan Bernardino$3K
- Nancy SelixMill Valley$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.